Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

✍ Scribed by T. Nishihori; T.J. Alekshun; D.M. Sullivan; M.A. Kharfan-Dabaja; J. Raychaudhuri; J.L. Ochoa-Bayona; K. Shain; D.N. Yarde; V. Oliviera; J. Pidala; W. Fulp; D.-T. Chen; J. Kim; C.M. Simonelli; B. Maddox; C. Anasetti; M. Alsina

• Book ID: 116282101
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 86 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.150